Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2017-02-10

View Filing

S-3 - Registration statement under Securities Act of 1933

Form Type: S-3

Filing Date: 2017-02-10

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2017-02-10

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2017-02-10

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2017-02-07

View Filing

CT ORDER - Confidential treatment order

Form Type: CT ORDER

Filing Date: 2017-02-02

View Filing

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2017-01-30

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2017-01-09

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2017-01-09

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2016-12-15

View Filing